戻る Agenda
Tethering the Channels of Scientific and Medical Content
Session Chair(s)
J. Lynn Bass, PHARMD, RPH
Medical Affairs Lead
Mesoblast, United States
Scientific communications are integral in channeling the activities within the clinical, medical, regulatory and other functional areas of pharmaceutical companies to ensure the safe and effective utilization of medications. As the internal drivers of scientific and medical content, Medical Science Liaisons, Medical Communications, and Medical Writing functions are being utilized to guide these communication channels and are responsible for the scientific interface with both customers and health care professionals. As companies and our industry evolve, it is imperative for communications from each of these functions be streamlined and coordinated. This session will discuss how each of these functional areas contributes to the overall scientific communications strategy in their unique modes. Best practices for working cross-functionally and an overview of tools for measuring success will be discussed.
Learning Objective : Discuss the unique roles of the medical communications, medical science liaison, and medical writing disciplines; Recognize how cross-functional departmental planning enhances medical communication practices; Identify best practices for successful cross-functional interactions to achieve value added deliverables.
Speaker(s)
Medical and Scientific Content
Jennifer Sliwa, PHARMD, RPH
Janssen Scientific Affairs, LLC, United States
Director, Medical Information
Medical Writing Contribution to Medical Communication Designed to Meet Customer Needs
David B. Clemow, PHD
Eli Lilly and Company, United States
Advisor, Scientific Communications Information Strategy